ANIP
Ani Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$81.84
+0.34 (+0.42%)
Open$82.42
Previous Close$81.50
Day High$82.42
Day Low$80.57
52W High$99.50
52W Low$54.10
Volume—
Avg Volume465.3K
Market Cap1.84B
P/E Ratio45.32
EPS$1.94
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-55.1% upside
Current
$81.84
$81.84
Target
$36.71
$36.71
$28.36
$36.71 avg
$54.52
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 714.59M | 504.44M | 655.83M |
| Net Income | -21,543,308 | -13,686,980 | 91.62M |
| Profit Margin | -3.0% | -2.9% | 14.0% |
| EBITDA | 66.08M | 44.32M | 150.31M |
| Free Cash Flow | — | — | 73.49M |
| Rev Growth | +41.7% | +41.7% | -1.8% |
| Debt/Equity | 1.46 | 1.46 | 0.47 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |